Khonsu Therapeutics
Developing therapeutic proteins for autoimmune & inflammatory indications in human & animal health
Khonsu Therapeutics is active in the biotechnology, therapeutics space based in European Union (EU), Europe, Middle East, and Africa (EMEA), founded in 2017.
The company sits in the biotechnology, therapeutics segment, where it competes on its core product or service.
European Union (EU), Europe, Middle East, and Africa (EMEA) is where the company is located.
Its current recorded stage is Private company.
Its team size is recorded as c_00001_00010 employees.
| Sector | Biotechnology, Therapeutics |
|---|---|
| Headquarters | European Union (EU), Europe, Middle East, and Africa (EMEA) |
| Founded | 2017 |
| Employees | c_00001_00010 |
| Stage | Private company |
Website: khonsutherapeutics.com
Sign in to view the contact information we hold for Khonsu Therapeutics.
Create a free account
Create a free account